The FDA might soon be approving a test that could mirror the affects of Alzheimer’s disease on the brain, showing in detail the plaque that tends to build up with this disease, causing serious symptoms such as severe memory loss.

The test is essentially a brain scan which is able to show more detail than any other test ever performed on someone with Alzheimer’s.

The good news is that the recommendation for the test is coming from the FDA advisory board and they usually follow their advice on most issues. They are simply waiting for approval from radiologists who have yet to weigh in as to what they think.

The advisory board knows what the FDA is after hard evidence and they are doing their best to help move the process along as quickly as possible.

The potentially groundbreaking scan involves a certain contrast dye which allows scientists and doctors to see the plaque which forms in the brain with Alzheimer’s patients, making it visible on standard PET scans which can go a long way towards starting treatment for those who are revealed to have it early on.

It is most definitely a step forward as far as early detection goes as well as studying the disease itself.

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *